Ewha Med J.  2021 Apr;44(2):37-40. 10.12771/emj.2021.44.2.37.

Active Surveillance of Papillary Thyroid Cancer: Past, Present, and Future

• Kim JK
• Kwon H
• Lim W
• Moon BI
• Paik NS

• KMID: 2515270
• DOI: http://doi.org/10.12771/emj.2021.44.2.37

Abstract

Active surveillance (AS) of papillary thyroid microcarcinoma was first suggested by Dr. Akira Miyauchi at Kuma Hospital in 1993. Based on several subsequent evidences, AS was approved by the American Thyroid Association in 2015. AS is no longer an experimental treatment but has become an acceptable standard of care for patients with low-risk thyroid cancers. No molecular markers, such as BRAF mutations, have been identified to predict the prognosis of papillary thyroid cancer. However, future molecular studies may reveal the relationship between genetic mutations and thyroid cancer prognosis. AS involves closely monitoring thyroid cancer over time, instead of immediately treating it with surgery. Patients and medical doctors should consider these two options: observation or surgery.

Keyword

Thyroid neoplasms; History; Therapeutics; Surgery; Watchful waiting

Reference

1. Roman BR, Morris LG, Davies L. 2017; The thyroid cancer epidemic, 2017 perspective. Curr Opin Endocriol Diabetes Obes. 24:332–336. DOI: 10.1097/MED.0000000000000359. PMID: 28692457. PMCID: PMC5864110.

2. Hirokawa M, Kudo T, Ota H, Suzuki A, Miyauchi A. 2016; Pathological chracteristics of low-risk papillary thyroid microcarcinoma with progression during active surveillance. Endocr J. 63:805–810. DOI: 10.1507/endocrj.EJ16-0097. PMID: 27397594.

3. Ito Y, Miyauchi A, Oda H. 2018; Low-risk papillary microcarcinoma of the thyeoid: A review of active surveillance trials. Eur J Surg Oncol. 44:307–315. DOI: 10.1016/j.ejso.2017.03.004. PMID: 28343733.

4. Hughes DT, Haymart MR, Miller BS, Gauger PG, Doherty GM. 2011; The most commonly occurring papillary thyroid cancer in the United States is now a microcarcinoma in a patient older than 45 years. Thyroid. 21:231–236. DOI: 10.1089/thy.2010.0137. PMID: 21268762.

5. Altekruse S, Das A, Cho H, Petkov V, Yu M. 2015; Do US thyroid cancer indidence rates increase with socioeconomic status among people with health insurance? An observational study using SEER population-based data. BMJ Open. 5:e009843. DOI: 10.1136/bmjopen-2015-009843. PMID: 26644126. PMCID: PMC4679945.

6. Davies L, Welch HG. 2006; Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 295:2164–2167. DOI: 10.1001/jama.295.18.2164. PMID: 16684987.

7. Ito Y, Miyauchi A, Kudo T, Oda H, Yamamoto M, Sasai H, et al. 2018; Trends in the implementation of active surveillance for low-risk papillary thyroid microcarcinomas at Kuma Hospital: Gradual increase and heterogenity in the acceptance of this new management option. Thyroid. 28:488–495. DOI: 10.1089/thy.2017.0448. PMID: 29608416. PMCID: PMC5905421.

8. Ito Y, Miyauchi A, Inoue H, Fukushima M, Kihara M, Higashiyama T, et al. 2010; An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J Surg. 34:28–35. DOI: 10.1007/s00268-009-0303-0. PMID: 20020290.

9. Ito Y, Miyauchi A, Kihara M, Higashiyama T, Kobayashi K, Miya A. 2014; Patient age is significantly related to the progression of pipillary microcarcinoma of the thyroid under observation. Thyroid. 24:27–34. DOI: 10.1089/thy.2013.0367. PMID: 24001104. PMCID: PMC3887422.

10. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nififorov YE, et al. 2016; 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guideleines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 26:1–133. DOI: 10.1089/thy.2015.0020. PMID: 26462967. PMCID: PMC4739132.

11. Lohia S, Hanson M, Tuttle RM, Morris LGT. 2020; Active surveillance for patients with very low-risk thyroid cancer. Laryngoscope Investig Otolaryngol. 5:175–182. DOI: 10.1002/lio2.356. PMID: 32128446. PMCID: PMC7042648.

12. Davies L, Welch HG. 2014; Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg. 140:317–322. DOI: 10.1001/jamaoto.2014.1. PMID: 24557566.

13. Miyauch A. 2016; Clinical trials of active surveillance of papillary microcarcinoma of the thyroid. World J Surg. 40:516–522. DOI: 10.1007/s00268-015-3392-y. PMID: 26744340. PMCID: PMC4746213.

14. Sugitani I, Toda K, Yamada K, Tamamoto N, Ikenaga M, Fujimoto Y. 2010; Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes. World J Surg. 34:1222–1231. DOI: 10.1007/s00268-009-0359-x. PMID: 20066418.

15. Kwon H, Oh HS, Kim M, Park S, Jeon MJ, Kim WG, et al. 2017; Active surveillance for patients with papillary thyroid microcarcinoma: A single center's experience in Korea. J Clin Endocrinol Metab. 102:1917–1925. DOI: 10.1210/jc.2016-4026. PMID: 28323932.

16. Tuttle RM, Fagin JA, Minkowitz G, Wong RJ, Roman B, Patel S, et al. 2017; Natural history and tumor volume kinetics of papillary thyroid cancers during active surveillance. JAMA Otolaryngol Head Neck Surg. 143:1015–1020. DOI: 10.1001/jamaoto.2017.1442. PMID: 28859191. PMCID: PMC5710258.

17. Brito JP, Ito Y, Miyauchi A, Tuttle RM. 2016; A clinical framework to gacilitate risk stratification when considering an active surveillance alternative to immediate biopsy and surgery in papillary microcarcinoma. Thyroid. 26:144–149. DOI: 10.1089/thy.2015.0178. PMID: 26414743. PMCID: PMC4842944.

18. Griffin A, Brito JP, Bahl M, Hoang JK. 2017; Applying criteria of active surveillance to low-risk papillary thyroid cancer over a decade: How many surgeries and complications can be avoided? Thyroid. 27:518–523. DOI: 10.1089/thy.2016.0568. PMID: 28125944.

19. Oda H, Miyauchi A, Ito Y, Sasai H, Masuoka H, Yabuta T, et al. 2017; Comparison of the costs of active surveillance and immediate surgery in the management of low-risk papillary microcarcinoma of the thyroid. Endocr J. 64:59–64. DOI: 10.1507/endocrj.EJ16-0381. PMID: 27667647.

20. Davies L, Roman BR, Fukushima M, Ito Y, Miyauchi A. 2019; Patient experience of thyroid cancer active surveillance in Japan. JAMA Otolaryngol Head Neck Surg. 145:363–370. DOI: 10.1001/jamaoto.2018.4131. PMID: 30703198. PMCID: PMC6481594.